150 related articles for article (PubMed ID: 31916369)
1. Evaluation of the economic burden of kidney stone disease in the UK: a retrospective cohort study with a mean follow-up of 19 years.
Geraghty RM; Cook P; Walker V; Somani BK
BJU Int; 2020 Apr; 125(4):586-594. PubMed ID: 31916369
[TBL] [Abstract][Full Text] [Related]
2. Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: A retrospective observational study (LuCaBIS).
Andreas S; Chouaid C; Danson S; Siakpere O; Benjamin L; Ehness R; Dramard-Goasdoue MH; Barth J; Hoffmann H; Potter V; Barlesi F; Chirila C; Hollis K; Sweeney C; Price M; Wolowacz S; Kaye JA; Kontoudis I
Lung Cancer; 2018 Oct; 124():298-309. PubMed ID: 29961557
[TBL] [Abstract][Full Text] [Related]
3. Renal stone disease in Christchurch, New Zealand. Part 2: a community study on the burden of renal stone disease.
Davidson PJ; Sheerin IG; Frampton C
N Z Med J; 2009 Jun; 122(1297):57-67. PubMed ID: 19649002
[TBL] [Abstract][Full Text] [Related]
4. The excess cost of acute exacerbations of chronic bronchitis in patients aged 45 and older in England and Wales.
McGuire A; Irwin DE; Fenn P; Gray A; Anderson P; Lovering A; MacGowan A
Value Health; 2001; 4(5):370-5. PubMed ID: 11705127
[TBL] [Abstract][Full Text] [Related]
5. Association of Kidney Stone Disease (KSD) with Primary Gastrointestinal Surgery: a Systematic Review over Last 2 Decades.
Premakumar Y; Gadiyar N; Hameed BMZ; Veneziano D; Somani BK
Curr Urol Rep; 2021 May; 22(6):34. PubMed ID: 34027628
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for kidney stone disease recurrence: a comprehensive meta-analysis.
Wang K; Ge J; Han W; Wang D; Zhao Y; Shen Y; Chen J; Chen D; Wu J; Shen N; Zhu S; Xue B; Xu X
BMC Urol; 2022 Apr; 22(1):62. PubMed ID: 35439979
[TBL] [Abstract][Full Text] [Related]
7. Primary SWL Is an Efficient and Cost-Effective Treatment for Lower Pole Renal Stones Between 10 and 20 mm in Size: A Large Single Center Study.
Chan LH; Good DW; Laing K; Phipps S; Thomas BG; Keanie JY; Tolley DA; Cutress ML
J Endourol; 2017 May; 31(5):510-516. PubMed ID: 28355100
[TBL] [Abstract][Full Text] [Related]
8. Worldwide Impact of Warmer Seasons on the Incidence of Renal Colic and Kidney Stone Disease: Evidence from a Systematic Review of Literature.
Geraghty RM; Proietti S; Traxer O; Archer M; Somani BK
J Endourol; 2017 Aug; 31(8):729-735. PubMed ID: 28338351
[TBL] [Abstract][Full Text] [Related]
9. The economic consequences of prostate and bladder cancer in the UK.
Sangar VK; Ragavan N; Matanhelia SS; Watson MW; Blades RA
BJU Int; 2005 Jan; 95(1):59-63. PubMed ID: 15638895
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness and efficiency of shockwave lithotripsy vs flexible ureteroscopic holmium:yttrium-aluminium-garnet laser lithotripsy in the treatment of lower pole renal calculi.
Koo V; Young M; Thompson T; Duggan B
BJU Int; 2011 Dec; 108(11):1913-6. PubMed ID: 21453346
[TBL] [Abstract][Full Text] [Related]
11. Association of body fat percentage with kidney stone Disease: a cross-sectional and longitudinal study among bus drivers.
Zheng X; Chen Q; Wu Y; Xiong J
BMC Public Health; 2023 Nov; 23(1):2174. PubMed ID: 37932777
[TBL] [Abstract][Full Text] [Related]
12. Estimating the cost of smoking to the NHS in England and the impact of declining prevalence.
Callum C; Boyle S; Sandford A
Health Econ Policy Law; 2011 Oct; 6(4):489-508. PubMed ID: 20735898
[TBL] [Abstract][Full Text] [Related]
13. Journey of a cystinuric patient with a long-term follow-up from a medical stone clinic: necessity to be SaFER (stone and fragments entirely removed).
Moore SL; Somani BK; Cook P
Urolithiasis; 2019 Apr; 47(2):165-170. PubMed ID: 29696300
[TBL] [Abstract][Full Text] [Related]
14. Penile cancer treatment costs in England.
Keeping ST; Tempest MJ; Stephens SJ; Carroll SM; Sangar VK
BMC Public Health; 2015 Dec; 15():1305. PubMed ID: 26715043
[TBL] [Abstract][Full Text] [Related]
15. Cost of schizophrenia to UK Society. An incidence-based cost-of-illness model for the first 5 years following diagnosis.
Guest JF; Cookson RF
Pharmacoeconomics; 1999 Jun; 15(6):597-610. PubMed ID: 10538332
[TBL] [Abstract][Full Text] [Related]
16. Economic burden of advanced melanoma in France, Germany and the UK: a retrospective observational study (Melanoma Burden-of-Illness Study).
Grange F; Mohr P; Harries M; Ehness R; Benjamin L; Siakpere O; Barth J; Stapelkamp C; Pfersch S; McLeod LD; Kaye JA; Wolowacz S; Kontoudis I
Melanoma Res; 2017 Dec; 27(6):607-618. PubMed ID: 28800027
[TBL] [Abstract][Full Text] [Related]
17. Primary prevention of nephrolithiasis is cost-effective for a national healthcare system.
Lotan Y; Buendia Jiménez I; Lenoir-Wijnkoop I; Daudon M; Molinier L; Tack I; Nuijten MJ
BJU Int; 2012 Dec; 110(11 Pt C):E1060-7. PubMed ID: 22686216
[TBL] [Abstract][Full Text] [Related]
18. Health economic burden that wounds impose on the National Health Service in the UK.
Guest JF; Ayoub N; McIlwraith T; Uchegbu I; Gerrish A; Weidlich D; Vowden K; Vowden P
BMJ Open; 2015 Dec; 5(12):e009283. PubMed ID: 26644123
[TBL] [Abstract][Full Text] [Related]
19. A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.
Buxton M; Caine N; Chase D; Connelly D; Grace A; Jackson C; Parkes J; Sharples L
Health Technol Assess; 2006 Aug; 10(27):iii-iv, ix-xi, 1-164. PubMed ID: 16904046
[TBL] [Abstract][Full Text] [Related]
20. The cost of epilepsy in the United Kingdom: an estimation based on the results of two population-based studies.
Cockerell OC; Hart YM; Sander JW; Shorvon SD
Epilepsy Res; 1994 Jul; 18(3):249-60. PubMed ID: 7805646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
